PTX3 and Ito hypomelanosis: Furthermore, PTX3 polymorphisms have been associated to reduced systemic levels of the protein and increased risk of IPA in recipients of hematopoietic stem-cell (HSC) (39, 45) and solid organ transplants (46), chronic obstructive pulmonary disease patients (47) and individuals with hematological malignancies (48).